X0206 3 2015-02-27 1 0001623613 Mylan N.V. MYL 0001113186 LEECH DOUGLAS J ALBANY GATE, DARKES LANE POTTERS BAR, HERTFORDSHIRE X0 EN6 1AG UNITED KINGDOM 1 0 0 0 On February 27, 2015 (the "Closing Date"), Mylan N.V. completed the transaction (the "Transaction") by which it acquired Mylan Inc. and Abbott Laboratories' ("Abbott") non-U.S. developed markets specialty and branded generics business (the "Business"). Pursuant to the terms of the Amended and Restated Business Transfer Agreement and Plan of Merger, dated as of November 4, 2014, by and among Mylan Inc., New Moon B.V. (which has been renamed Mylan N.V. and is referred to herein as "Mylan"), Moon of PA Inc. ("Merger Sub"), and Abbott, on the Closing Date, Mylan acquired the Business and Merger Sub merged with and into Mylan Inc., with Mylan Inc. surviving as a wholly owned indirect subsidiary of Mylan and each share of Mylan Inc. common stock issued and outstanding was cancelled and automatically converted into and became the right to receive one Mylan ordinary share. In connection with the Transaction, Mylan Inc. and the Business have been reorganized under Mylan, a new public company organized in the Netherlands. This report reflects the beneficial ownership of the reporting person at the time of the consummation of the Transaction and does not include the securities of Mylan acquired by the reporting person upon the consummation of the Transaction. The reporting person will file a Form 4 reflecting his acquisition of Mylan securities in connection with the consummation of the Transaction. Exhibit 24 - Power of Attorney /s/ Bradley L. Wideman, by power of attorney 2015-02-27